Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

TENX 3.52 +0.07 (2.03%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
MORRISVILLE, N.C., Sep 16, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the ...
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Form 8-K TENAX THERAPEUTICS, INC. For: Apr 09
On April 9, 2015, the Board of Directors of Tenax Therapeutics, Inc. (the �Company�) approved a change in the Company's fiscal year to a fiscal year beginning on January 1 and ending on December 31 of each year, such change beginning as of January 1, ...
Tenax Therapeutics Provides Clinical and Corporate Update  Finances.com
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings Call Transcript. Dec. 17, 2014 1:19 PM ET | About: Tenax Therapeutics, Inc. (TENX) by: SA Transcripts. Tenax Therapeutics Inc. (NASDAQ:TENX). Q2 2015 Earnings Conference ...
Related articles »  
Tenax Therapeutics to Present at Cowen & Company 35th Annual Health Care ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Tenax Therapeutics Announces Third Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q3 2015 Results - Earnings ...  Seeking Alpha (registration)
Tenax Therapeutics (TENX) Releases Earnings Results, Beats Expectations By ...  The Legacy
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares. In a recent wave of reductions, the fund has dumped approximately 2.37 million shares in 10 transactions at prices varying between $10.95 and ...
Related articles »  
Tenax Therapeutics Issues Employment Inducement Award With Appointment of ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today confirmed Paula Bokesch, M.D.
Tenax Therapeutics (TENX) Jumps: Stock Moves Up 7.8%
Tenax Therapeutics, Inc. (TENX - Snapshot Report) was a big mover last session, as its shares rose nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »  
Tenax Therapeutics Announces Analyst Day and Webcast on April 13, 2015
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the company will ...